Condensed Separate Interim statement of other Comprehensive Income for the period ended June 30, 2020 | | | | Last 6 Months | | | Last 6 Months | | | | | | | Jun. 30, 2020 | | | Jun. 30, 2019 | | | | | | | EGP Thousands | | | EGP Thousands | | | | | | | | | | | | | | Net profit for the period | | | 5,001,609 | | | 5,358,020 | | | | | | | | | | | | | | Net change in fair value of instruments measured at fair value through other comprehensive income | | | (1,483,581) | | | 2,838,861 | | | | Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income | | | 90,512 | | | (109,668) | | | | Total other comprehensive income for the period | | | 3,608,540 | | | 8,087,213 | | | |
Condensed Separate Interim Cash flows for the period ended June 30, 2020 | | | | | | | | | Notes | Jun. 30, 2020 | | Jun. 30, 2019 | | | | EGP Thousands | | EGP Thousands | | | | | | | | Cash flow from operating activities | | | | | | Profit before income tax | | 7,546,216 | | 7,399,456 | | Adjustments to reconcile net profit to net cash provided by operating activities | | | | | | Fixed assets depreciation | 14 | 328,251 | | 275,052 | | Impairment charge for credit losses (Loans and advances to customers and banks) | | 2,144,988 | | 875,635 | | Other provisions charges | 17 | 1,096,888 | | 3,140 | | Impairment charge for credit losses (due from banks) | | 24,154 | | 29,156 | | Impairment charge for credit losses (financial investments) | | 90,512 | | (109,667) | | Impairment charge for other assets | | 24,621 | | 52,772 | | Exchange revaluation differences for financial assets at fair value through OCI | | (85,180) | | 886,795 | | Intangible assets amortization | | - | | 65,104 | | Impairment charge financial assets at fair value through OCI | | - | | 45,664 | | Exchange differences in financial investments in subsidiary | 13 | (242) | | 3,020 | | Utilization of other provisions | 17 | (1,066) | | 1,878 | | Other provisions no longer used | 17 | (43,200) | | (126,575) | | Exchange differences of other provisions | 17 | 3,011 | | (69,724) | | (Profits) losses from selling property, plant and equipment | | (94) | | (1,439) | | (Profits) losses from selling financial investments | 12 | (924,720) | | (65,445) | | Shares based payments | | 296,959 | | 247,998 | | Released (Impairment) charges of investments in associates and subsidiaries | | 14,100 | | - | | Released (Impairment) charges of FVOCI equity instruments | | 78,615 | | - | | Operating profits before changes in operating assets and liabilities | | 10,593,813 | | 9,512,820 | | | | | | | | Net decrease (increase) in assets and liabilities | | | | | | Due from banks | 8 | (507,846) | | (25,049,337) | | Treasury bills and other governmental notes | | - | | 24,315,394 | | Financial assets at fair value through P&L | 12 | 61,477 | | 2,262,513 | | Derivative financial instruments | | (41,469) | | (75,592) | | Loans and advances to banks and customers | 10 - 11 | (2,430,817) | | (4,776,117) | | Other assets | | 925,679 | | 1,289,326 | | Due to banks | 15 | 460,488 | | (5,879,606) | | Due to customers | 16 | 14,460,587 | | 20,263,230 | | Income tax obligations paid | | (4,639,364) | | (3,625,579) | | Other liabilities | | (2,962,457) | | (1,225,572) | | Net cash provided from operating activities | | 15,920,091 | | 17,011,480 | | | | | | | | Cash flow from investing activities | | | | | | Proceeds from investments in associates. | | 750 | | - | | Payments for investment in subsidiaries. | | (560,963) | | - | | Payment for purchases of property, plant, equipment and branches
constructions | | (625,596) | | (840,953) | | Proceeds from selling property, plant and equipment | | 94 | | 1,439 | | Proceeds from redemption of financial assets at amortized cost | | 59,360,102 | | 33,290,053 | | Payment for purchases of financial assets at amortized cost | | (44,945,839) | | (32,633,462) | | Payment for purchases of financial assets at fair value through OCI | | (50,506,453) | | (11,433,512) | | Proceeds from selling financial assets at fair value through OCI | | 55,237,128 | | 5,105,870 | | Net cash used in investing activities | | 17,959,223 | | (6,510,565) | | | | | | | | | Cash flow from financing activities | | | | | | Increase (decrease) in long term loans | | (22,492) | | (230,801) | | Dividend paid | | (3,370,464) | | (2,700,544) | | Net cash used in (provided from) financing activities | | (3,392,956) | | (2,931,345) | | | | | | | | | | | | | | Net increase (decrease) in cash and cash equivalent during the period | | 30,486,358 | | 7,569,570 | | Beginning balance of cash and cash equivalent | | 22,895,017 | | 34,303,645 | | Cash and cash equivalent at the end of the period | | 53,381,375 | | 41,873,215 | | | | | | | | Cash and cash equivalent comprise: | | | | | | Cash and balances with central bank | 7 | 30,421,432 | | 24,993,377 | | Due from banks | 8 | 56,818,722 | | 66,543,158 | | Treasury bills and other governmental notes | 9 | 27,424,702 | | 25,344,096 | | Obligatory reserve balance with CBE | 7 | (22,905,156) | | (15,980,212) | | Due from banks with maturities more than three months | | (10,266,781) | | (33,329,274) | | Treasury bills with maturity more than three months | | (28,111,544) | | (25,697,930) | | Total cash and cash equivalent | | 53,381,375 | | 41,873,215 | | | | | | | | | | | | | |
| | | | | | | | | |